Skip to main content
SpringerLink
Log in

Skin Cancer

  • Chapter
  • First Online:
Handbook of Evidence-Based Radiation Oncology

  • 2775 Accesses

Abstract

Skin cancer is the most common malignancy in the USA and its incidence is increasing. Work-up, treatment, and relevant literature for major subtypes of skin cancer are discussed. Since the last edition, targeted therapies and immunotherapies have revolutionized skin cancer management, and these advances are also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Agrawal S, Kane JM, Guadagnolo BA, Kraybill WG, Ballo MT. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Cancer (Wiley Subscription Services, Inc., A Wiley Company). 2009;115(24):5836–44.

    Google Scholar 

  • Anwar M, Yu Y, Glastonbury CM, El-Sayed IH, Yom SS. Delineation of radiation therapy target volumes for cutaneous malignancies involving the ophthalmic nerve (cranial nerve V-1) pathway. Pract Radiat Oncol. 2016;6(6):e277–81.

    Article  Google Scholar 

  • Ganti AK, Macha M, Batra S. Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma. CMAR (Dove Press). 2013;5:197–203.

    Article  Google Scholar 

  • Atherton P, Townley J, Glaholm J. Cartilage: the “F-”factor fallacy. Clin Oncol. 1993;5(6):391–2.

    Article  CAS  Google Scholar 

  • Balch CM, Soong S, Ross MI, Urist MM, Karakousis CP, Temple WJ, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup melanoma surgical trial. Ann Surg Oncol. 2000;7(2):87–97.

    Article  CAS  Google Scholar 

  • Ballo MT, Bonnen MD, Garden AS, Myers JN, Gershenwald JE, Zagars GK, et al. Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer (Wiley Subscription Services, Inc., A Wiley Company). 2003;97(7):1789–96.

    Google Scholar 

  • Beadle BM, Guadagnolo BA, Ballo MT, Lee JE, Gershenwald JE, Cormier JN, et al. Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys (Elsevier). 2009;73(5):1376–82.

    Article  Google Scholar 

  • Caccialanza M, Piccinno R, Gaiani F, Contini D. Relevance of dermatologic radiotherapy in the therapeutic strategy of skin epithelial neoplasms: excellent results in the treatment of lesions localized on eyelids and skin overlying the cartilage of the nose. G Ital Dermatol Venereol. 2013;148(1):83–8.

    CAS  PubMed  Google Scholar 

  • Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet. 1998;351(9105):793–6.

    Article  CAS  Google Scholar 

  • American Academy of Dermatology Ad Hoc Task Force for the ABCDEs of Melanoma, Tsao H, Olazagasti JM, Cordoro KM, Brewer JD, Taylor SC, Bordeaux JS, Chren MM, Sober AJ, Tegeler C, Bhushan R, Begolka WS. Early detection of melanoma: reviewing the ABCDEs. J Am Acad Dermat (Elsevier). 2015;72(4):717–23.

    Article  Google Scholar 

  • Chandra RA, Wilhite TJ, Balboni TA, Alexander BM, Spektor A, Ott PA, et al. A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab. Oncoimmunology (Taylor & Francis). 2015;4(11):e1046028.

    Article  Google Scholar 

  • Chen MM, Roman SA, Sosa JA, Judson BL. The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients. JAMA Otolaryngol Head Neck Surg (American Medical Association). 2015;141(2):137–41.

    Article  Google Scholar 

  • Cognetta AB, Howard BM, Heaton HP, Stoddard ER, Hong HG, Green WH. Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients. J Am Acad Dermatol. 2012;67(6):1235–41.

    Article  Google Scholar 

  • Cognetta AB, Mendenhall WM. In: Cognetta AB, Mendenhall WM, editors. Radiation therapy for skin cancer. New York: Springer Science & Business Media; 2013.

    Chapter  Google Scholar 

  • Erovic I, Erovic BM. Merkel cell carcinoma: the past, the present, and the future. J Skin Cancer. 2013;2013(1):1–6.

    Article  Google Scholar 

  • Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096–100.

    Article  CAS  Google Scholar 

  • Gluck I, Ibrahim M, Popovtzer A, Teknos TN, Chepeha DB, Prince ME, et al. Skin cancer of the head and neck with perineural invasion: defining the clinical target volumes based on the pattern of failure. Int J Radiat Oncol Biol Phys. 2009;74(1):38–46.

    Article  Google Scholar 

  • Grimaldi AM, Simeone E, Giannarelli D, Muto P, Falivene S, Borzillo V, et al. Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy. Oncoimmunology. 2014;3(5):e28780.

    Article  Google Scholar 

  • Hanna E, Abadi R, Abbas O. Imiquimod in dermatology: an overview. Int J Dermatol. 2016;55(8):831–44.

    Article  CAS  Google Scholar 

  • Hasan S, Liu L, Triplet J, Li Z, Mansur D. The role of postoperative radiation and chemoradiation in merkel cell carcinoma: a systematic review of the literature. Front Oncol (Frontiers). 2013;3:276.

    Google Scholar 

  • Henderson MA, Burmeister BH, Ainslie J, Fisher R, Di Iulio J, Smithers BM, et al. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial. Lancet Oncol (Elsevier). 2015;16(9):1049–60.

    Article  Google Scholar 

  • Hernández-Machin B, Borrego L, Gil-García M, Hernández BH. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments. Int J Dermatol (Blackwell Publishing Ltd). 2007;46(5):453–9.

    Article  Google Scholar 

  • Jaju PD, Ransohoff KJ, Tang JY, Sarin KY. Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors. J Am Acad Dermatol. 2016;74(3):437–51. quiz452–4

    Article  Google Scholar 

  • Jouary T, Leyral C, Dreno B, Doussau A, Sassolas B, Beylot-Barry M, et al. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol. 2012;23(4):1074–80.

    Article  CAS  Google Scholar 

  • Karia PS, Jambusaria-Pahlajani A, Harrington DP, Murphy GF, Qureshi AA, Schmults CD. Evaluation of American joint committee on cancer, International Union against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma. J Clin Oncol (American Society of Clinical Oncology). 2014;32(4):327–34.

    Article  Google Scholar 

  • Lacouture ME, Dréno B, Ascierto PA, Dummer R, Basset-Seguin N, Fife K, et al. Characterization and management of hedgehog pathway inhibitor-related adverse events in patients with advanced basal cell carcinoma. Oncologist. 2016;21(10):1218–29.

    Article  Google Scholar 

  • Locke J, Karimpour S, Young G, Lockett MA, Perez CA. Radiotherapy for epithelial skin cancer. Radiat Oncol Biol. 2001;51(3):748–55.

    Article  CAS  Google Scholar 

  • Lok B, Khan S, Mutter R, Liu J, Fields R, Pulitzer M, et al. Selective radiotherapy for the treatment of head and neck Merkel cell carcinoma. Cancer (Wiley Subscription Services, Inc., A Wiley Company). 2012;118(16):3937–44.

    Google Scholar 

  • Manyam B, Garsa AA, Chin RI, Reddy CA, Gastman B, Vidimos AT, et al. A multi-institutional comparison of outcomes of immunocompromised and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2016;94(4):–948.

    Article  Google Scholar 

  • McDermott PN, Orton CG. The physics & technology of radiation therapy. Madison: Medical Physics Publishing Corporation; 2010.

    Google Scholar 

  • McDowell LJ, Young RJ, Johnston ML, Tan T-J, Kleid S, Liu CS, et al. p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: no association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary. Cancer. 2016;122(8):1201–8.

    Article  CAS  Google Scholar 

  • Mendenhall WM, Shaw C, Amdur RJ, Kirwan J, Morris CG, Werning JW. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence. Am J Otolaryngol (Elsevier). 2013;34(4):320–2.

    Article  Google Scholar 

  • Mojica P, Smith D, Ellenhorn JDI. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol (American Society of Clinical Oncology). 2007;25(9):1043–7.

    Article  Google Scholar 

  • Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med (Massachusetts Medical Society). 2014;370(7):599–609.

    Article  CAS  Google Scholar 

  • Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet. 1995;345(8949):540–3.

    Article  CAS  Google Scholar 

  • Sause WT, Cooper JS, Rush S, Ago CT, Cosmatos D, Coughlin CT, et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Radiat Oncol Biol. 1991;20(3):429–32.

    Article  CAS  Google Scholar 

  • Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012;366(23):2171–9.

    Article  CAS  Google Scholar 

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.

    Article  Google Scholar 

  • Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc. 1986;61(9):697–705.

    Article  CAS  Google Scholar 

  • Strom T, Caudell JJ, Han D, Zager JS, Yu D, Cruse CW, et al. Radiotherapy influences local control in patients with desmoplastic melanoma. Cancer (7 ed.). 2014;120(9):1369–78.

    Article  Google Scholar 

  • Swartz JL, Griffith KA, Lowe L, et al. Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol. 2011;29(8):1036–41.

    Article  Google Scholar 

  • Touzé A, Le Bidre E, Laude H, Fleury MJJ, Cazal R, Arnold F, et al. High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome. J Clin Oncol (American Society of Clinical Oncology). 2011;29(12):1612–9.

    Article  Google Scholar 

  • Veness MJ, Howle J. Cutaneous carcinoma. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. 4th ed. Philadelphia: Clinical Radiation Oncology; 2016. p. 763–776.e2.

    Chapter  Google Scholar 

  • Veronesi U, Adamus J, Bandiera DC, Brennhovd O, Caceres E, Cascinelli N, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer. 1982;49(11):2420–30.

    Article  CAS  Google Scholar 

  • Wang JT, Palme CE, Morgan GJ, Gebski V, Wang AY, Veness MJ. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: improved survival with the addition of adjuvant radiotherapy. Head Neck (Wiley Subscription Services, Inc., A Wiley Company). 2011;34(11):1524–8.

    Google Scholar 

  • Moore AY. Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders. J Dermatol Treat. 2009;20(6):328–35.

    Article  Google Scholar 

Download references

Acknowledgment

We thank Tania Kaprealian, MD, James Rembert, MD, and Lawrence W. Margolis, MD, for their work on prior editions of this chapter.

Author information

Authors and Affiliations

  1. Radiation Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA

    Lisa Singer

  2. Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA

    Sue S. Yom

Authors
  1. Lisa Singer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sue S. Yom
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sue S. Yom .

Editor information

Editors and Affiliations

  1. The Oregon Clinic, Providence St. Vincent Medical Center, Portland, OR, USA

    Eric K. Hansen

  2. Department of Radiation Oncology, University of California, San Franc, SAN FRANCISCO, CA, USA

    Mack Roach III

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Singer, L., Yom, S.S. (2018). Skin Cancer. In: Hansen, E., Roach III, M. (eds) Handbook of Evidence-Based Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-62642-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-62642-0_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-62641-3

  • Online ISBN: 978-3-319-62642-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation